Skip to content

USE OF ERANDMULADI YAPANA BASTI AND PRAJASTHAPANA GHANA VATI (AYURVEDIC MEDICINE)IN FEMALE INFERTILITY

ROLE OF ERANDMULADI YAPANA BASTI AND PRAJASTHAPANA GHANA VATI IN VANDHYATVA (FEMALE INFERTILITY) W.S.R. TO ANOVULATORY FACTOR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/006052
Enrollment
40
Registered
2015-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation Health Condition 2: null- female patients of infertility

Interventions

Intervention1: Erandmuladi Yapana Basti: Group A patients will receive Erandmuladi Yapana Basti during 2 consecutive menstrual cycle.Total 36 Erandmuladi Yapana Basti will be administered. 18 Erandmul

Sponsors

Institute for Post Graduate Teaching and Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having active married life (minimum 1 year). 2. Married female patients of reproductive age group with atleast 2 or more consecutive anovulatory cycles. 3. Primary and secondary both types of infertile patients having anovulatory cycle or with immature ovarian follicle.

Exclusion criteria

Exclusion criteria: 1. Patients having age less than 18 years and more than 40 years. 2. Patients suffering from disorders of reproductive tract like tuberculosis, carcinoma, and congenital deformities; Sexually transmitted diseases will be excluded.

Design outcomes

Primary

MeasureTime frame
�To evaluate the effect of selected Ayurvedic drugs and procedure on ovulation and to compare their efficacy (Based on TVS USG)Timepoint: �To evaluate the effect of1. Conceptual StudyTill June 2014 2. Clinical StudyTill March 2015

Secondary

MeasureTime frame
� To evaluate the effect on menstrual abnormalities, Dysmenorrhoea, etc. if any. � To evaluate the role of Deha Prakruti in manifestation of a disease and treatment effect. Timepoint: 1. Conceptual StudyTill June 2014 2. Clinical StudyTill March 2015

Countries

India

Contacts

Public ContactDR SHILPA B DONGA

Institute for Post Graduate Teaching and Research in Ayurveda GAU Jamnagar

baghelayu@rediffmail.com9427207964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 5, 2026